| Autologous CD117+ Progenitor Cell Mobilization for Lung Transplantation (NCT01916577) | University of Colorado, Denver | 2013-08-01 |
| The Addition of Non-Invasive Ventilation To Airway Clearance Techniques In Adults With Cystic Fibrosis (NCT01885650) | Royal Brompton & Harefield NHS Foundation Trust | 2013-07-01 |
| Pharmacokinetics of Piperacillin, Given as Continuous Infusion to Patients With Cystic Fibrosis (NCT01983787) | University of Aarhus | 2013-07-01 |
| A Phase 1 Study to Investigate the Food Effect of Lumacaftor in Combination With Ivacaftor (NCT01899105) | Vertex Pharmaceuticals Incorporated | 2013-07-01 |
| Effects of an Exercise Program Among CF Patients With Dysglycemia (NCT02127957) | Institut de Recherches Cliniques de Montreal | 2013-07-01 |
| At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions (NCT01931644) | Sanguine Biosciences | 2013-07-01 |
| The Effects of Massage Therapy on QOL in Youth/Young Adults With Cystic Fibrosis (NCT01729585) | Children's Hospital Medical Center, Cincinnati | 2013-07-01 |
| Pulmozyme in Cystic Fibrosis With Sinusitis (NCT01155752) | Milton S. Hershey Medical Center | 2013-07-01 |
| Study of Lumacaftor in Combination With Ivacaftor in Subjects 6 Through 11 Years of Age With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation (NCT01897233) | Vertex Pharmaceuticals Incorporated | 2013-07-01 |
| Comparing Laboratory Blood Glucose Results With HemoCue Glucose 201 RT (NCT01883037) | Royal Brompton & Harefield NHS Foundation Trust | 2013-06-01 |
| Effect of Chronic Incretin-based Therapy in Cystic Fibrosis (NCT01879228) | University of Pennsylvania | 2013-06-01 |
| Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in Cystic Fibrosis (NCT01859390) | University of Colorado, Denver | 2013-06-01 |
| Crossover Trial Determining the Efficacy of Dry Powder Mannitol to Improve Lung Function in Subjects Aged 6-17 Years (NCT01883531) | Syntara | 2013-06-01 |
| Repeatability and Response Study of Absorptive Clearance Scans (NCT01887197) | Tim Corcoran | 2013-06-01 |
| Phase 1, QT/QTC Interval Study in Healthy Subjects (NCT01910415) | Vertex Pharmaceuticals Incorporated | 2013-06-01 |
| DNA Methylation and Lung Disease in Cystic Fibrosis (NCT02884622) | University Hospital, Montpellier | 2013-06-01 |
| Evaluating Sensations of Breathlessness in Patients With Cystic Fibrosis (NCT01799642) | University of British Columbia | 2013-06-01 |
| Phase 1b Safety, Tolerability, and PK Study to Assess GS-5737 in Subjects With CF (NCT01840735) | Gilead Sciences | 2013-05-01 |
| Viral Pathogenesis of Early Cystic Fibrosis Lung Disease (NCT01973192) | Indiana University | 2013-05-01 |
| Beta-cell Response to Incretin Hormones in Cystic Fibrosis (NCT01851694) | University of Pennsylvania | 2013-05-01 |
| Genetics of Insulin and Incretins in Cystic Fibrosis (NCT01852448) | Children's Hospital of Philadelphia | 2013-05-01 |
| Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis (NCT01710644) | Nordmark Arzneimittel GmbH & Co. KG | 2013-05-01 |
| An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis (NCT01863238) | Vertex Pharmaceuticals Incorporated | 2013-05-01 |
| Canadian Observation Trial in CF Patients Undergoing Treatment With Ivacaftor (NCT03390985) | Tanja Gonska | 2013-04-23 |
| Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis Adults (NCT02368080) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2013-04-01 |
| Comparing Chest Images From MRI to CT in Patients With Cystic Fibrosis (CF) (NCT01860872) | Children's Hospital Medical Center, Cincinnati | 2013-04-01 |
| Cough-Generated Aerosols of NTM in Cystic Fibrosis (NCT01815866) | University of Florida | 2013-04-01 |
| High Flow Nasal Oxygen for Children With Cystic Fibrosis Presenting With Respiratory Failure - a Randomized Controlled Study (NCT01810536) | University of Sao Paulo | 2013-04-01 |
| Correlation Between Haptoglobin Phenotypes and Infectious and Other Complications in Cystic Fibrosis Patients (NCT01806025) | Carmel Medical Center | 2013-04-01 |
| Pilot Trial of Phototherapy for Acute Depression in Hospitalized Cystic Fibrosis Patients (NCT01822197) | Nationwide Children's Hospital | 2013-03-01 |
| Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients (NCT01746095) | Savara Inc. | 2013-03-01 |
| Modulation of Intestinal and Pulmonary Inflammation by Lactobacillus Diet Supplementation in Pediatric Cystic Fibrosis (NCT01837355) | Cantonal Hospital of St. Gallen | 2013-02-22 |
| Extrapulmonary Effects of Cystic Fibrosis on Physical Activity of Adult Patients. (NCT01848392) | Assistance Publique - Hôpitaux de Paris | 2013-02-21 |
| Using MRI to Observe Lung Changes in Infants With CF Compared to Infants Without CF (NCT01832519) | Children's Hospital Medical Center, Cincinnati | 2013-02-01 |
| Aerosolized Hypertonic Xylitol Versus Hypertonic Saline in Cystic Fibrosis (CF) Subjects (NCT00928135) | Joseph Zabner | 2013-01-22 |
| Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation (NCT01705145) | Vertex Pharmaceuticals Incorporated | 2013-01-01 |
| Renal Failure Following Lung Transplantation in Cystic Fibrosis Patients (NCT05001841) | Policlinico Hospital | 2013-01-01 |
| ECMO for Lung Transplantation in Cystic Fibrosis Patients (NCT03919604) | Policlinico Hospital | 2013-01-01 |
| Puberty in Girls Followed for Cystic Fibrosis (NCT02562911) | University Hospital, Toulouse | 2013-01-01 |
| Bone Microarchitecture in Young Cystic Fibrosis Patients (NCT01788267) | Hospices Civils de Lyon | 2013-01-01 |
| Near Patient Microbial Testing in Cystic Fibrosis (NCT01877707) | Papworth Hospital NHS Foundation Trust | 2013-01-01 |
| A Phase 1 Study to Examine the Drug-Drug Interaction of Ciprofloxacin, Itraconazole, and Rifampin on the Combination of Lumacaftor With Ivacaftor in Healthy Adult Subjects (NCT01768663) | Vertex Pharmaceuticals Incorporated | 2013-01-01 |
| Sputum Purulence as a Predictor of Cystic Fibrosis Exacerbations: a Prospective Cohort Trial. (NCT02309229) | Universitaire Ziekenhuizen KU Leuven | 2012-12-01 |
| A Study of the Comparable Efficacy and Safety of Pulmozyme (Dornase Alfa) Delivered by the eRapid Nebulizer System in Patients With Cystic Fibrosis (NCT01712334) | Genentech, Inc. | 2012-12-01 |
| Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment (NCT01695343) | Humanigen, Inc. | 2012-12-01 |
| Biomarkers of Injury and Destruction in the Cystic Fibrosis Lung (NCT01805713) | University of Minnesota | 2012-12-01 |
| Timing of Hypertonic Saline Inhalation Relative to Airways Clearance in Cystic Fibrosis (NCT01753869) | Belfast Health and Social Care Trust | 2012-12-01 |
| Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF (NCT01641822) | Gilead Sciences | 2012-12-01 |
| Treatment of Dysglycemia Using Sitagliptin in Adolescents With Cystic Fibrosis (NCT01721382) | Nemours Children's Clinic | 2012-11-01 |
| Extension Study of Liposomal Amikacin for Inhalation in Cystic Fibrosis (CF) Patients With Chronic Pseudomonas Aeruginosa (Pa) Infection (NCT01316276) | Insmed Incorporated | 2012-10-05 |
| A Phase 1 Study to Characterize the Effect of GS-5737 Enhancement of Mucociliary Clearance (MCC) in Healthy Subjects (NCT01793649) | Gilead Sciences | 2012-10-01 |
| Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP) (NCT01594827) | Johns Hopkins University | 2012-10-01 |
| Non Invasive Ventilation as Airway Clearance in Patients With Cystic Fibrosis (NCT02083263) | Karolinska University Hospital | 2012-10-01 |
| Web-based Delivery of Effective Treatment for Growth in Cystic Fibrosis (NCT01686672) | Children's Hospital Medical Center, Cincinnati | 2012-10-01 |
| Retrospective Observational Study to Compare Cystic Fibrosis Patients in Two Decades Before and After 2000 (NCT01651455) | Chiesi Farmaceutici S.p.A. | 2012-09-01 |
| Cough Efficiency in Cystic Fibrosis (NCT01636219) | Sheba Medical Center | 2012-09-01 |
| Evaluation of the Timing of the Nebulization Related to the Physiotherapy Session (NCT02201082) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2012-09-01 |
| Pilot Study Testing the Effect of Ivacaftor on Lung Function in Subjects With Cystic Fibrosis and Residual CFTR Function (NCT01685801) | Vertex Pharmaceuticals Incorporated | 2012-09-01 |
| Continuous Infusion Piperacillin-tazobactam for the Treatment of Cystic Fibrosis (NCT01694069) | West Virginia University | 2012-09-01 |
| A Study Comparing Continuous Infusion Antibiotics to Standard Treatment for Lung Infections in Cystic Fibrosis (NCT01667094) | The Alfred | 2012-09-01 |
| Detection of Pseudomonas Aeruginosa in the Airways of Patients With CF (NCT01303068) | University of New Mexico | 2012-08-15 |
| Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis (NCT01684410) | Grifols Therapeutics LLC | 2012-08-01 |
| Microbiome Acquisition and Progression of Inflammation and Airway Disease in Infants and Children With Cystic Fibrosis (NCT01661491) | Yale University | 2012-08-01 |
| Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients (NCT02190604) | Novartis Pharmaceuticals | 2012-07-31 |
| CF And Effects of Drugs Mixed Ex Vivo With Sputum for Mucolytic Treatment (NCT01533636) | University of California, San Francisco | 2012-07-17 |
| Study of Ivacaftor in Subjects With Cystic Fibrosis (CF) Who Have the R117H-CF Transmembrane Conductance Regulator (CFTR) Mutation (KONDUCT) (NCT01614457) | Vertex Pharmaceuticals Incorporated | 2012-07-01 |
| Study of Ivacaftor in Subjects With Cystic Fibrosis (CF) Who Have a Non-G551D CF Transmembrane Conductance Regulator (CFTR) Gating Mutation (NCT01614470) | Vertex Pharmaceuticals Incorporated | 2012-07-01 |
| Flaxseed Modulates Inflammation and Oxidative Stress in CF (NCT02014181) | University of Pennsylvania | 2012-07-01 |
| Assessment of Fat Free Mass Index and Its Impact on Health in Children With Cystic Fibrosis (NCT01401439) | University of Arkansas | 2012-06-01 |
| Repeated Application of Gene Therapy in CF Patients (NCT01621867) | Imperial College London | 2012-05-01 |
| INSPIRE-CF: an Alternative Physiotherapy Model for Children With Cystic Fibrosis (NCT01889927) | Great Ormond Street Hospital for Children NHS Foundation Trust | 2012-05-01 |
| Prevention of Bronchiectasis in Infants With Cystic Fibrosis (NCT01270074) | The University of Queensland | 2012-04-01 |
| Electro Flo 5000 and Vest Therapy (NCT02277626) | Stanford University | 2012-04-01 |
| Predictive Value of PIIINP Urinary for the Development of Chronic Renal Failure in Patients With Cystic Fibrosis After Lung Transplantation (MUCO-IRC) (NCT01572194) | Nantes University Hospital | 2012-04-01 |
| Prognostic Value of Functional Exercise Test (EFX) in Cystic Fibrosis (NCT02994017) | University Hospital, Lille | 2012-03-05 |
| Effect of Azithromycin on Fatty Acids in CF (NCT03045198) | University Childrens' Hospital (Zentrum für Kinderheilkunde des Universitätsklinikum Bonn) | 2012-03-01 |
| Effect of Glycine in Cystic Fibrosis (NCT01417481) | Instituto Nacional de Enfermedades Respiratorias | 2012-03-01 |
| Metabolic Efficiency of Combined Pancreatic Islet and Lung Transplant for the Treatment of End-Stage Cystic Fibrosis (NCT01548729) | University Hospital, Strasbourg, France | 2012-02-25 |
| Impact of Global Care of the Pain at Chronic Painful Patients Affected by Cystic Fibrosis (NCT01915875) | Assistance Publique - Hôpitaux de Paris | 2012-02-15 |
| The Carrier Rates of Pseudomonas Aeruginosa in Family Members of Children With Cystic Fibrosis (NCT01616862) | Zafer Soultan | 2012-02-01 |
| A Safety and Tolerability Study OF PUR118 In Subjects With Cystic Fibrosis (NCT01543191) | Pulmatrix Inc. | 2012-02-01 |
| Study of VX-661 Alone and in Combination With Ivacaftor in Subjects Homozygous or Heterozygous to the F508del-Cystic Fibrosis Transmembrane Conductance Regulator(CFTR) Mutation (NCT01531673) | Vertex Pharmaceuticals Incorporated | 2012-02-01 |
| Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children (NCT01429259) | Joseph Kuti | 2012-02-01 |
| Quantitative Computed Tomodensitometry in Patients With Cystic Fibrosis (NCT01837589) | Hôpital Necker-Enfants Malades | 2012-01-01 |
| A Study of Sweat Testing Using a Quantitative Patch (NCT01345617) | Polychrome Medical, Inc. | 2012-01-01 |
| Action of Epigenetic Modifiers in Cystic Fibrosis Treatment (NCT01883284) | University Hospital, Montpellier | 2012-01-01 |
| Pharmacokinetics of Vancomycin for Inhalation in Cystic Fibrosis (NCT01509339) | Case Western Reserve University | 2012-01-01 |
| Elastography of the Liver in Cystic Fibrosis Patients. Diagnostic and Prognostic Aspects (NCT02603666) | Karolinska University Hospital | 2012-01-01 |
| Clinical Study With an Enteral Formula With Symbiotic and DHA for Malnourished Children (NCT02128984) | Laboratorios Ordesa | 2012-01-01 |
| Tobramycin 300 mg Once-a-day (o.d.) Aerosol in Adults With Cystic Fibrosis (NCT01608555) | University of Milan | 2012-01-01 |
| Imaging Lung Function Using Oxygen Enhanced MRI (NCT01731015) | Hal C Charles | 2012-01-01 |
| Sweat Evaporimeter Measurement (NCT01708655) | University of Colorado, Denver | 2011-12-01 |
| Baby Observational and Nutritional Study (NCT01424696) | Seattle Children's Hospital | 2011-12-01 |
| Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways (NCT01404234) | Gilead Sciences | 2011-12-01 |
| Clinical Evaluation of NeoPlex4 Assay and NeoPlex System (NCT01488721) | Luminex Corporation | 2011-12-01 |
| Functional Analysis by Dynamic Imaging of the Respiratory Epithelium in Infants With Cystic Fibrosis (NCT01605565) | Institut National de la Santé Et de la Recherche Médicale, France | 2011-11-01 |
| Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF) (NCT00889434) | Hadassah Medical Organization | 2011-11-01 |
| Inhaled Vancomycin Tolerability, Safety and Pharmacokinetics (NCT01537666) | Savara Inc. | 2011-11-01 |
| A Randomized-Controlled Trial of Inhaled Hypertonic Saline (7%) to Evaluate the Lung Clearance Index (NCT02276898) | The Hospital for Sick Children | 2011-11-01 |
| Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC Study) (NCT01426256) | Emory University | 2011-10-01 |